Carmila S.A. (LON:0QAP)
16.62
+0.03 (0.20%)
At close: Dec 12, 2025
Carmila Revenue
Carmila had revenue of 303.29M EUR in the half year ending June 30, 2025, with 18.77% growth. This brings the company's revenue in the last twelve months to 570.17M, up 18.43% year-over-year. In the year 2024, Carmila had annual revenue of 525.34M with 9.83% growth.
Revenue (ttm)
570.17M EUR
Revenue Growth
+18.43%
P/S Ratio
4.22
Revenue / Employee
2.19M EUR
Employees
260
Market Cap
2.06B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 525.34M | 47.01M | 9.83% |
| Dec 31, 2023 | 478.32M | 15.90M | 3.44% |
| Dec 31, 2022 | 462.42M | 18.37M | 4.14% |
| Dec 31, 2021 | 444.05M | 7.61M | 1.74% |
| Dec 31, 2020 | 436.44M | -17.23M | -3.80% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| Barclays | 26.02B |